Please login to the form below

Not currently logged in
Email:
Password:

CAR-T

This page shows the latest CAR-T news and features for those working in and with pharma, biotech and healthcare.

ASCO: Momentum gathers behind next wave of CAR-T therapies

ASCO: Momentum gathers behind next wave of CAR-T therapies

big hit for Johnson &Johnson, whose CAR-T is trailing a Bristol-Myers Squibb therapy that is nevertheless closest to market. ... If approved, the off-the-shelf CAR-T would be a rival to marketed autologous therapies from Gilead and Novartis.

Latest news

More from news
Approximately 49 fully matching, plus 154 partially matching documents found.

Latest Intelligence

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    The interleukin-6 receptor antagonist is approved for use in indications including the management of cytokine release syndrome in CAR-T patients.

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    Thanks to the CAR construct, the engineered T cells can recognise and attack the CD19-expressing cancer cells. ... This composition could confer efficacy and safety advantages, including fewer adverse effects such as cytokine release syndrome (CRS) and

  • China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances

    At the spear point is China’s emergence as the epicentre of biotech research and development, with its performance on CAR-T therapies turning heads. ... It now has more than 300 CAR-T clinical trials underway and collaboration with European and

  • European biotech: a new generation of leaders emerges European biotech: a new generation of leaders emerges

    year. The promise of the molecule is great, with analysts seeing it as a possible challenge to Novartis and Gilead’s CAR-T therapies. ... This means its clinical outcomes could match those seen in the CAR-Ts, but without the complexity and cost of

  • The dawn of a new era in medical education The dawn of a new era in medical education

    Innovation is not without its challenges. Let’s take haematology as our case study; there has been a flurry of revolutionary cell therapies to treat blood cancers, including CAR-T therapies.

More from intelligence
Approximately 1 fully matching, plus 52 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • The impossible launch

    SpaceX is inspiring people in a way that NASA hasn’t managed in over 30 years. ... Today’s therapy advances, such as CAR-T and gene therapy, are just as exciting and will help shape our world in the years to come.

  • Perspective: the patient edition

    The ALS patient journey. An article on CAR-T service design. Thought provoking content on clinical trial access and the social determinants of healthcare, and on precision and personalised medicine.

  • The balancing act that’s keeping pharma and biotech market access on its toes

    CAR-T cell therapy costs  close to $500, 000 per patient in the US, and  300, 000 in Europe.

  • Launch Excellence 2020

    How can you use insights to understand customers decision-making behaviour? What are you missing in your CAR-T service launch?

  • Understanding the evolving CAR-T market

    The CAR-T was their last chance and only hope. Astoundingly, 83% achieved overall remission within just three months of treatment. ... Today, the CAR-T market is expected to increase at an annual rate of 30% until 2030.

More from PMHub
Approximately 4 fully matching, plus 10 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

AI and genomics: a revolution in drug discovery and development
...
Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....

Infographics